Figures & data
Table 1 Number of COPD patients and prescriptions of each medication from 2008 to 2013
Table 2 Changes in the cost of prescribed medication for COPD per patient over the 6 years (all costs are in US dollars)
Table 3 Change in the number of prescriptions and cost over the 6 years (all costs are in US$1,000)
Figure 1 Change in the number of LABA prescriptions over the 6 years.
Abbreviation: LABA, long-acting beta-2 agonist.
Figure 2 Change in the number of LAMA prescriptions over the 6 years.
Figure 3 Change in the number of ICS prescriptions over the 6 years.
Figure 4 Change in the number of ICS + LABA prescriptions over the 6 years.
Figure 5 Change in the number of PDE-4 inhibitor prescriptions over the 6 years.
Figure 6 Change in the number of LTRA prescriptions over the 6 years.
Figure 7 Change in the number of OCS prescriptions over the 6 years.
Figure 8 Change in the number of SABA prescriptions over the 6 years.
Abbreviation: SABA, short-acting beta-2 agonist.
Figure 9 Change in the number of SAMA prescriptions over the 6 years.
Abbreviation: SAMA, short-acting muscarinic antagonist.
Figure 10 Change in the number of SABA + SAMA prescriptions over the 6 years.
Figure 11 Change in the number of methylxanthine prescriptions over the 6 years.
Figure 12 Change in the number of systemic beta agonist prescriptions over the 6 years.
